- A government-funded study on ultraprocessed foods pays participants $5,000 to follow diets rich in items like chicken nuggets. Preliminary results suggest these foods lead to higher calorie intake and weight gain, potentially shaping health policies.
- Weight-loss drugs like Ozempic are altering food preferences, encouraging less processed options.
- Food brands are adapting to “GLP-1 friendly” labels while researchers study potential long-term risks, such as vision loss.
Full Story
A new government-funded study is examining the health effects of ultraprocessed foods. Participants are being paid $5,000 to follow a diet heavy in processed items like chicken nuggets.
The Associated Press got an exclusive look into the study conducted at a government research facility. Its goal is to understand how these foods impact overall health. Researchers are particularly interested in ultraprocessed foods, which make up over 73% of the U.S. food supply, according to a Nature Communications study.
Point phone camera here
Junk food and health risks
Under strict supervision, participants alternated between ultraprocessed and less processed diets. Scientists monitored their calorie intake and physiological responses.
Early findings suggest that ultraprocessed foods lead to significantly higher calorie consumption and weight gain. One researcher told Fortune that the study’s short duration could limit results. However, the data may still influence future health policies.
“Make America Healthy Again” initiative
The study aligns with efforts by Health and Human Services Secretary Robert F. Kennedy Jr. His “Make America Healthy Again” initiative promotes the removal of certain artificial dyes and additives from food.
While Kennedy’s focus is on children’s health, he argues that ultraprocessed foods harm all age groups. However, one group may already be adjusting their diets.
Weight-loss drugs changing eating habits
A New York Times study highlights that GLP-1 weight-loss drugs, like Ozempic and Wegovy, are altering consumer habits. One subject, a former sugar addict, now finds processed sweets unappealing.
A professor at New York University told the Times that these drugs reduce appetites and rewire food preferences. Many users crave fresher, less processed options.
Big food companies react to shifting trends
Major food companies are feeling the effects of these dietary shifts. A PwC study found that GLP-1 users spend 11% less on food, particularly salty snacks and baked goods.
In response, brands like Conagra are launching “GLP-1 friendly” products. These items are labeled as high-protein and low-calorie to attract consumers using weight-loss medications.
Long-term effects of weight-loss drugs
However, the rise of GLP-1 drugs is not without concerns. Researchers are now studying their long-term effects. A February study is investigating a possible link between these medications and vision loss.
[KENNEDY FELTON]
A new government-funded study is putting ultra-processed foods under scrutiny, paying participants $5,000 to eat diets rich in items like chicken nuggets. As weight-loss drugs like Ozempic curb appetites and reshape eating habits, could this research mark the beginning of the end for junk food as we know it?
The Associated Press had an exclusive look at a National Institutes of Health study where participants spent a month in a government hospital. The study aimed to explore how certain foods impact health, given existing research on increased cancer risk and inflammation linked to ultra-processed foods, which make up more than 73% of the U.S. food supply, according to a Nature Communications study.
Participants, under strict supervision, ate as little or as much of the provided ultra-processed foods while scientists monitored their calorie intake and physiological responses. Although one researcher pointed out the study’s short length as a limitation, preliminary results revealed participants consumed significantly more calories on an ultra-processed diet, leading to weight gain—findings that could influence future health policies.
The “Make America Healthy Again” initiative, led by Health and Human Services Secretary Robert F. Kennedy Jr., seeks to improve public health. As part of this effort, food companies are being urged to remove harmful additives like artificial dyes from their products to enhance safety. However, when it comes to junk food, some groups may already be benefiting from these changes.
The rise of GLP-1 weight-loss drugs such as Ozempic and Wegovy is transforming eating habits. A New York Times article highlighted one user, a man once struggling with sugar addiction, who now finds himself unable to tolerate sweet treats. According to a historian and professor at NYU, these drugs not only suppress appetite but also alter food preferences, encouraging consumers to favor fresher, less processed options.
Major food companies are adapting to this shift. A PwC study revealed that GLP-1 users spend about 11% less on most food categories, especially salty snacks and baked goods. Brands like Conagra have started labeling products as “GLP-1 friendly,” emphasizing high-protein and low-calorie options to attract this evolving consumer base.
While these drugs offer new hope for weight-loss solutions, researchers are also examining their long-term effects. One recent study is investigating a potential link between these medications and vision loss.
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
MOST POPULAR
-
Reuters
Attorney General Pam Bondi warns Tesla vandals: ‘We’re coming after you’
-
Getty Images
Lutnick floats Trump idea of no income tax for people earning less than $150K
-
Reuters
American Airlines plane catches fire after emergency landing in Denver
-
Getty Images
Columbia announces punishments for pro-Palestine protesters
